Literature DB >> 9266980

Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles.

R J Sugrue1, J Fu, J Howe, Y C Chan.   

Abstract

We have expressed cDNA encoding the dengue virus structural proteins in Pichia pastoris by chromosomal integration of an expression cassette containing the dengue virus structural genes (CprME). The yeast recombinant E protein migrated during SDS-PAGE as a 65 kDa protein when analysed by Western blotting and radioimmunoprecipitation, which is the expected molecular mass for correctly processed and glycosylated E protein. Treatment with endoglycosidases showed that the recombinant E protein was modified by the addition of short mannose chains. The E protein migrated with a buoyant density of 1.13 g/cm3 when analysed using sucrose density gradient centrifugation. Spherical structures with an average diameter of 30 nm, whose morphology resembles dengue virions, were observed in the purified fractions using transmission electron microscopy. Furthermore, the virus-like particles were immunogenic in animals and were able to induce neutralizing antibodies. This is the first report that expression of the structural genes of a flavivirus in yeast is able to generate particulate structures that resemble virions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266980     DOI: 10.1099/0022-1317-78-8-1861

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2.

Authors:  Smita Jaiswal; Navin Khanna; S Swaminathan
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction.

Authors:  Jiraphan Junjhon; Matthawee Lausumpao; Sunpetchuda Supasa; Sansanee Noisakran; Adisak Songjaeng; Prakaimuk Saraithong; Kridsada Chaichoun; Utaiwan Utaipat; Poonsook Keelapang; Amornrat Kanjanahaluethai; Chunya Puttikhunt; Watchara Kasinrerk; Prida Malasit; Nopporn Sittisombut
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

3.  An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.

Authors:  Akane Urakami; Mya Myat Ngwe Tun; Meng Ling Moi; Atsuko Sakurai; Momoko Ishikawa; Sachiko Kuno; Ryuji Ueno; Kouichi Morita; Wataru Akahata
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

4.  Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties.

Authors:  Wenquan Liu; Hanning Jiang; Junmei Zhou; Xiaomeng Yang; Yunxia Tang; Danyun Fang; Lifang Jiang
Journal:  Virus Genes       Date:  2009-11-03       Impact factor: 2.332

5.  Formation of Virus-Like Particles of the Dengue Virus Serotype 2 Expressed in Silkworm Larvae.

Authors:  Doddy Irawan Setyo Utomo; Ichikawa Hirono; Tatsuya Kato; Enoch Y Park
Journal:  Mol Biotechnol       Date:  2019-11       Impact factor: 2.695

6.  Expression in Pichia pastoris and immunological evaluation of a truncated Dengue envelope protein.

Authors:  Iris Valdés; Lisset Hermida; Aída Zulueta; Jorge Martín; Ricardo Silva; Mayling Alvarez; María G Guzmán; Gerardo Guillén
Journal:  Mol Biotechnol       Date:  2007-01       Impact factor: 2.695

Review 7.  The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.

Authors:  Beth-Ann G Coller; David E Clements; Andrew J Bett; Sangeetha L Sagar; Jan H Ter Meulen
Journal:  Vaccine       Date:  2011-07-21       Impact factor: 3.641

8.  Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.

Authors:  David E Clements; Beth-Ann G Coller; Michael M Lieberman; Steven Ogata; Gordon Wang; Kent E Harada; J Robert Putnak; John M Ivy; Michael McDonell; Gary S Bignami; Iain D Peters; Julia Leung; Carolyn Weeks-Levy; Eileen T Nakano; Tom Humphreys
Journal:  Vaccine       Date:  2010-01-22       Impact factor: 3.641

9.  Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.

Authors:  Jennifer Schepp-Berglind; Min Luo; Danher Wang; Jason A Wicker; Nicholas U Raja; Brian D Hoel; David H Holman; Alan D T Barrett; John Y Dong
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

10.  Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.

Authors:  Shailendra Mani; Lav Tripathi; Rajendra Raut; Poornima Tyagi; Upasana Arora; Tarani Barman; Ruchi Sood; Alka Galav; Wahala Wahala; Aravinda de Silva; Sathyamangalam Swaminathan; Navin Khanna
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.